Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (61-70 of 345) with videos related to

Pageof 35
Sort By:
Scientific Reports|August 26, 2020
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expressionShirin Karimi, Sheila Mansouri, Yasin Mamatjan, et al.
Journal of Neuro-Oncology|February 25, 2023
The multiomic landscape of meningiomas: a review and updateJustin Z Wang, Farshad Nassiri, Alexander P Landry, et al.
Journal of Neuro-Oncology|April 19, 2024
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapseKevin J Bielamowicz, Mary Beth Littrell, Gregory W Albert, et al.
Journal of Neuropathology and Experimental Neurology|August 1, 2024
A case of a (not so) diffuse leptomeningeal glioneuronal tumor with an unusual clinical historyChristina Abi Faraj, Ian E McCutcheon, Donald F Schomer, et al.
Nature|September 28, 2017
Corrigendum: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activationWeiwei Yang, Yan Xia, Haitao Ji, et al.
Molecular Cancer|September 15, 2005
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic lossJ Matthew McDonald, Valerie Dunmire, Ellen Taylor, et al.
Journal of Neuropathology and Experimental Neurology|December 31, 2025
Myxoid glioneuronal tumors can harbor unusual PDGFRA alterationsIlay Caliskan, Felipe D'Almeida Costa, Peter Jelsma, et al.
Cancer Immunology Research|January 11, 2014
Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlasTiffany Doucette, Ganesh Rao, Arvind Rao, et al.
Neuro-Oncology|June 10, 2011
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitorsMelissa M Singh, Christa A Manton, Krishna P Bhat, et al.
Journal of Neuropathology and Experimental Neurology|January 19, 2023
First-time identification of a KIF5B-NTRK2 fusion in extraventricular neurocytomaMaria A Gubbiotti, Mariarita Santi, Philip B Storm, et al.
Pageof 35

Showing results (61-70 of 345) with videos related to

Sort By:
Pageof 35
Scientific Reports|August 26, 2020
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expressionShirin Karimi, Sheila Mansouri, Yasin Mamatjan, et al.
Journal of Neuro-Oncology|February 25, 2023
The multiomic landscape of meningiomas: a review and updateJustin Z Wang, Farshad Nassiri, Alexander P Landry, et al.
Journal of Neuro-Oncology|April 19, 2024
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapseKevin J Bielamowicz, Mary Beth Littrell, Gregory W Albert, et al.
Journal of Neuropathology and Experimental Neurology|August 1, 2024
A case of a (not so) diffuse leptomeningeal glioneuronal tumor with an unusual clinical historyChristina Abi Faraj, Ian E McCutcheon, Donald F Schomer, et al.
Nature|September 28, 2017
Corrigendum: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activationWeiwei Yang, Yan Xia, Haitao Ji, et al.
Molecular Cancer|September 15, 2005
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic lossJ Matthew McDonald, Valerie Dunmire, Ellen Taylor, et al.
Journal of Neuropathology and Experimental Neurology|December 31, 2025
Myxoid glioneuronal tumors can harbor unusual PDGFRA alterationsIlay Caliskan, Felipe D'Almeida Costa, Peter Jelsma, et al.
Cancer Immunology Research|January 11, 2014
Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlasTiffany Doucette, Ganesh Rao, Arvind Rao, et al.
Neuro-Oncology|June 10, 2011
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitorsMelissa M Singh, Christa A Manton, Krishna P Bhat, et al.
Journal of Neuropathology and Experimental Neurology|January 19, 2023
First-time identification of a KIF5B-NTRK2 fusion in extraventricular neurocytomaMaria A Gubbiotti, Mariarita Santi, Philip B Storm, et al.
Pageof 35